Citation Bureau
Vol. I
No. 358
XIII SEPTEMBER MMXXVI
Organization

What is FTC?

The Federal Trade Commission (FTC) is a United States government agency that enforces consumer protection and antitrust laws. Commentary in 2026 focused on how its review powers shape dealmaking, from licensing structures that avoid merger scrutiny to the costs of blocked acquisitions.

Company timeline

  • Jul 2026 - Mark Cuban said corporate development teams were told to stand down amid four years of no acquisitions.
  • Sep 2026 - Christina Lee said Cambridge Analytica was an outlier because the FTC’s order came after the company was defunct, making it a summary judgment rather than a settlement.
  • Sep 2026 - Nathaniel Whittemore said structuring deals as non-exclusive licensing agreements avoids automatic FTC review and cannot be blocked the way traditional mergers and acquisitions can.

Where it appears in the record

Every line below is attributed to a named speaker.

Best explained

Structuring AI deals as non-exclusive licensing agreements avoids automatic FTC review and cannot be blocked the way traditional M&A can.

“By structuring the deals as non-exclusive licensing agreements, they don't trigger automatic review by the FTC and can't be blocked in the same way as traditional mergers and acquisitions.”
Nathaniel Whittemore · 12 Sep 2026
Contrarian take

The FTC's Cambridge Analytica enforcement order was not a negotiated settlement but a summary judgment, making it an outlier in FTC algorithmic enforcement because the firm was already defunct when the order issued.

“Cambridge Analytica is actually a bit of an outlier because by the time that all of this all of the FTC's order came through Cambridge Analytica was defunct. So Cambridge was actually a summary judgment as opposed to a settlement.”
Christina Lee · 8 Sep 2026
Contrarian take

Lina Khan's FTC effectively froze M&A for four years, with corporate development teams explicitly told to stand down, a market-distorting effect that is now reversing.

“4 years of no acquisitions. I people I talked to who were in corporate development were like, we've been told to stand down.”
Mark Cuban · 21 Jul 2026
By the numbers

An FTC-blocked biotech acquisition resulted in a drug never being developed; 50 people die per year as a consequence, per an anecdote Browder relays.

“The worst kind of Lena Khan story I heard is there's like a biotech company that was being acquired by a much larger kind of pharmaceutical company and Lena Khan's FDC blocked the acquisition and to this day and the drug didn't get developed and to this day 50 people die a year because of the acquisition being blocked.”
Josh Browder · 18 May 2026
Citation Bureau · reference note, compiled from attributed expert discussion. Last updated 2026-09-13.